Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
89°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Weight management
Recent news which mentions Weight management
If you invested $1,000 in drugmaker Eli Lilly 10 years ago, here's how much money you'd have now
August 08, 2024
Tags
Make It
Weight management
Pharmaceuticals
From
CNBC.com News
This ETF is trying to satisfy appetites for weight loss stocks
July 06, 2024
Tags
Novo Nordisk A/S
ETF Edge
Health care costs
From
CNBC.com News
Why half of all workers may struggle to get weight-loss drug health insurance coverage
May 30, 2024
Tags
Eli Lilly and Co
Health care industry
Labor economy
From
CNBC.com News
Weight loss drug Wegovy is now approved for heart health — but that won't mean broad insurance coverage just yet
March 16, 2024
Tags
Health & Science
Renter's insurance
Business News
From
CNBC.com News
The big health decisions Americans will need to make after starting new weight loss drugs
February 28, 2024
Tags
Weight loss diets
Health & Science
Health
From
CNBC.com News
The pet drugs vets are now prescribing look a lot more like human medications
February 28, 2024
Tickers
CATS
DOGS
PETS
Tags
CNBC Changemakers
Diabetes
Eli Lilly and Co
From
CNBC.com News
What you need to know about health insurance coverage for new weight loss drugs, and how to save on costs
February 16, 2024
Tags
Obesity
Health insurance
Weight management
From
CNBC.com News
Weight loss drugs are still hard to find — but Novo Nordisk and Eli Lilly are trying to change that
February 10, 2024
Tags
Roche Holding AG
Eli Lilly and Co
Health care industry
From
CNBC.com News
The weight loss drug boom isn't over yet — here's what to expect in the year ahead
December 17, 2023
Tags
Health care industry
Eli Lilly and Co
Roche Holding AG
From
CNBC.com News
Pfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effects
December 01, 2023
Tags
Biotech and Pharmaceuticals
Pfizer Inc
Novo Nordisk A/S
From
CNBC.com News
Eli Lilly results top estimates on Mounjaro strength but slashes full-year profit outlook
November 02, 2023
Tags
Novo Nordisk A/S
Biotech and Pharmaceuticals
Earnings
From
CNBC.com News
As Ozempic and Wegovy take off, this tech startup just raised $20 million to tackle weight loss with data
October 24, 2023
Tags
Enterprise
Mobile
Technology
From
CNBC.com News
'Miracle drug' euphoria: Experts warn widespread use of weight loss medicine faces major hurdles
October 14, 2023
Tags
Weight loss diets
Exercise
Biotechnology
From
CNBC.com News
How Ozempic and Wegovy turned Novo Nordisk into a $400 billion company
October 10, 2023
Tickers
CEO
Tags
Business
Weight management
Pharmaceuticals
From
CNBC.com News
Ozempic, Wegovy drug prescriptions hit 9 million, surge 300% in under three years
September 27, 2023
Tags
Breaking news
Weight management
Pharmaceuticals
From
CNBC.com News
Ozempic, Wegovy may curb drinking, smoking and other addictive behaviors – here's what we know
September 10, 2023
Tags
Biotech and Pharmaceuticals
Novo Nordisk A/S
Health care industry
From
CNBC.com News
Ozempic could be the next target of Medicare drug price negotiations – here's why
August 31, 2023
Tags
Policy
Medicare health plans
Diabetes
From
CNBC.com News
Weight loss drugs boost sales at retail pharmacies, but they may not help profits much
August 21, 2023
Tags
Business News
Health & Science
US: News
From
CNBC.com News
Wegovy could prevent up to 1.5 million heart attacks, strokes over 10 years, study says
August 16, 2023
Tags
Science
Stroke
Breaking news
From
CNBC.com News
Novo Nordisk to acquire obesity drug maker Inversago Pharma for up to $1 billion
August 10, 2023
Tags
Novo Nordisk A/S
Biotech and Pharmaceuticals
Health care industry
From
CNBC.com News
Insurers face long road, high cost to cover obesity drugs after promising Wegovy heart health data
August 09, 2023
Tags
Health & Science
Business News
US: News
From
CNBC.com News
Eli Lilly says obesity drug helped boost weight loss to 26%, highest seen in late-stage trials
July 27, 2023
Tags
Biotech and Pharmaceuticals
Novo Nordisk A/S
Clinical trials
From
CNBC.com News
UK investigates weight loss, diabetes drugs like Wegovy and Ozempic for suicide risks
July 26, 2023
Tags
Europe News
Novo Nordisk A/S
Biotech and Pharmaceuticals
From
CNBC.com News
Eli Lilly to acquire obesity drug maker Versanis for $1.9 billion
July 14, 2023
Tags
Business News
Health & Science
Biotechnology
From
CNBC.com News
EU expands Wegovy, Ozempic probe over suicide risks to include other weight loss, diabetes drugs
July 11, 2023
Tags
Breaking news
Suicides
Weight management
From
CNBC.com News
Few patients continue weight loss drugs like Wegovy after a year — but health costs soar for all
July 11, 2023
Tags
Health care industry
Diabetes
Eli Lilly and Co
From
CNBC.com News
People should stop taking Ozempic, Wegovy obesity drugs before surgery, doctors group says
June 30, 2023
Tags
Surgical procedures
Weight management
Pharmaceuticals
From
CNBC.com News
TikTokers say berberine is 'nature's Ozempic': Here's what doctors want you to know about the buzzy supplement
June 28, 2023
Tags
Make It / Life
Medication
Health Tips and Wellness Advice
From
CNBC.com News
As drugmakers race to develop the next big weight loss pill, Eli Lilly may have an edge
June 28, 2023
Tags
Business
Weight management
Pharmaceuticals
From
CNBC.com News
Novo Nordisk says high-dose experimental obesity pill leads to 15% weight loss
June 26, 2023
Tags
Diabetes
Eli Lilly and Co
Health care industry
From
CNBC.com News
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.